Photic entrainment of circadian rhythms in rodents

Chronobiology International

Volumn 15, Issue 5, 1998, Pages 395-423

  Rea, Michael A ^a,b,c  

^a AIR FORCE RESEARCH LABORATORY   (United States)

^b Univ of Texas Health Science Center ^*  (United States)

^c UNIVERSITY OF HOUSTON   (United States)

Author keywords

Glutamate; Immediate early genes; Nitric oxide; Phase shifts; Serotonin

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMIC ACID; NITRIC OXIDE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR;

CIRCADIAN RHYTHM; GENE EXPRESSION; HYPOTHALAMUS; IMMEDIATE EARLY GENE; LIGHT DARK CYCLE; NERVE TRACT; NEUROTRANSMISSION; NONHUMAN; PHOTORECEPTOR; PHOTOSTIMULATION; RAT; REVIEW; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS; VISUAL SYSTEM;

EID: 0031710493     PISSN: 07420528     EISSN: None     Source Type: Journal    
DOI: 10.3109/07420529808998699     Document Type: Review

References (227)

1. Klein DC, Moore RY, Reppert SM. Suprachiasmatic nucleus: the mind's clock. New York: Oxford University Press, 1991.
2. Daan S, Pittendrigh CS. A functional analysis of circadian pacemakers in nocturnal rodents: II The variability of phase response curves. J Comp Physiol 1976; 106:253-66.
3. DeCoursey, PJ. Function of a light response rhythm in hamsters. J Cell Comp Physiol 1964; 63:189-96.
4. Pittendrigh CS, Daan S. A functional analysis of circadian pacemakers in nocturnal rodents. IV. Entrainment: pacemaker as clock. J Comp Physiol 1976; 106: 291-331.
5. Takahashi JS, DeCoursey PJ, Bauman L, Menaker M. Spectral sensitivity of a novel photoreceptive system mediating entrainment of mammalian circadian rhythms. Nature 1984; 308:556-61.
6. Czeisler CA. The effect of light on the human circadian pacemaker. In: Chadwick DJ, and Ackrill K, eds. Circadian clocks and their adjustment, Ciba Foundation Symposium, Chichester: Wiley, 1995, 183:254-302.
7. Rusak B, Zucker I. Neural regulation of circadian rhythms. Physiol Rev 1979; 59: 449-526.
8. Travnickova Z, Sumova A, Peters R, Schwartz WJ, Illnerova H. Photoperiod-dependent correlation between light-induced SCN c-fos expression and resetting of circadian phase. Am J Physiol 1996; 271:R825-R831.
9. Moore RY, Karapas F, Lenn NJ. A retinohypothalamic projection in the rat. Anat Res 1971; 169:382-83.
10. Moore RY, Lenn NL. A retinohypothalamic projection in the rat. J Comp Neurol 1972; 146:1-14.
11. Hendrickson AE, Wagoner N, Cowan WN. An autoradiographic and electron microscopic study of retinohypothalamic connections. Z Zellforsch 1972; 135:1-26.
12. Moore RY. Retinhoypothalamic projection in mammals: a comparative study. Brain Res 1973; 51:403-9.
13. Pickard GE, Silverman AJ. Direct retinal projections to the hypothalamus, piriform cortex and accessory optic nuclei in the golden hamster as demonstrated by a sensitive anterograde horseradish peroxidase technique. J Comp Neurol 1981; 196:155-72.
14. Johnson RF, Moore RY, Morin LP. Retinohypothalamic projections in the rat and hamster demonstrated using cholera toxin. Brain Res 1988; 462:301-12.
15. Swanson LW, Cowan WM, Jones EG. An autoradiographic study of the efferent connections of the ventral lateral geniculate nucleus in the albino rat and cat. J Comp Neurol 1974; 156:143-64.
16. Card JP, Moore RY. Ventral lateral geniculate nucleus efferents to the rat suprachiasmatic nucleus exhibit avian pancreatic polypeptide-like immunoreactivity. J Comp Neurol 1982; 206:390-96.
17. Card JP, Moore RY. Organization of lateral geniculate-hypothalamic connections in the rat. J Comp Neurol 1989; 284:135-47.
18. Pickard GE. The afferent connections of the suprachiasmatic nucleus of the golden hamster with emphasis on the retinohypothalamic projection. J Comp Neurol 1982; 211:65-83.
19. Moore RY, Card JP. The intergeniculate leaflet: an anatomically and functionally distinct subdivision of the lateral geniculate complex. J Comp Neurol 1994; 344: 403-30.
20. Mikkelsen JD, Vrang N. A direct pretecto-suprachiasmatic projection in the rat. Neuroscience 1994; 62:497-505.
21. Moore RY, Klein DC. Visual pathways and the central neural control of a circadian rhythm in pineal serotonin N-acetyltransferase activity. Brain Res 1974; 71:17-33.
22. Johnson RF, Moore RY, Morin LP. Loss of entrainment and anatomical plasticity after lesions of the hamster retinohypothalamaic tract. Brain Res 1988; 460:297-313.
23. Pickard GE. Bifurcating axons of retinal ganglion cells terminate in the hypothalamic suprachiasmatic nucleus and the intergeniculate leaflet of the thalamus. Neurosci Lett 1985; 55:211-17.
24. Harrington ME, Rusak B. Lesions of the thalamic intergeniculate leaflet alter hamster circadian rhythms. J Biol Rhythms 1986; 1:309-25.
25. Pickard GE, Ralph MR, Menaker M. The intergeniculate leaflet mediates effects of light on circadian rhythms. J Biol Rhythms 1987; 2:35-56.
26. Pickard GE. Entrainment of the circadian rhythm of wheel running activity is phase shifted by ablation of the intergeniculate leaflet. Brain Res 1989; 494: 151-54.
27. Janik D, Mrosovsky N. Intergeniculate leaflet lesions and behaviorally-induced shifts of circadian rhythms. Brain Res 1994; 651:174-82.
28. Mrosovsky N. A non-photic gateway to the circadian clock of hamsters. In: Chadwick DJ, Ackrill K, eds. Circadian clocks and their adjustment, Ciba Foundation Symposium, Chichester: Wiley, 1995, 183:154-74.
29. Morin LP. The circadian visual system. Brain Res Brain Res Rev 1994; 19:102-27.
30. Groos GA, Mason R. Maintained discharge of rat suprachiasmatic neurons at different adaptation levels. Neurosci Lett 1978; 8:59-64.
31. Groos GA, Mason R. The visual properties of rat and cat suprachiasmatic neurones. J Comp Physiol 1980; 135:349-56.
32. Meijer JH, Groos, GA, Rusak B. Luminance coding in a circadian pacemaker: the suprachiasmatic nucleus of the rat and the hamster. Brain Res 1986; 382:109-18.
33. Nelson DE, Takahashi JS. Sensitivity and integration in a visual pathway for circadian entrainment in the hamster (Mesocricetus auratus). J Physiol (London) 1991; 439:115-45.
34. Marriott FHC. The foveal absolute threshold for short flashes and small fields. J Physiol 1963; 169:416-23.
35. Emerson VF. Grating acuity in the golden hamster: the effects of stimulus orientation and luminance. Exp Brain Res 1980; 38:43-52.
36. Murakami DK, Miller JD, Fuller CA. The retinohypothalamic tract in the cat: retinal ganglion cell morphology and pattern of projection. Brain Res 1989; 482: 283-96.
37. Pickard GE. Morphological characterization of retinal ganglion cells projecting to suprachiasmatic nucleus: a horseradish peroxidase study. Brain Res 1980; 183: 458-65.
38. Moore RY, Speh JC, Card JP. The retinohypothalamic tract originates from a distinct subset of retinal ganglion cells. J Comp Neurol 1995; 352:351-66.
39. Card JP, Whealy ME, Robbins AK, Moore RY, Enquist LW. Two alpha herpes virus strains are transported differently in the rodent visual system. Neuron 1991; 6:957-69.
40. McCall MA, Gregg RG, Stanford LR. Transgenic modification of the mouse retina. Soc Neurosci Abst 1992; 18:138.
41. Argamaso SM, Froehlich AC, McCall MA, Nevo E, Provencio I, Foster RG. Photopigments and circadian systems of vertebrates. Biophys Chem 1995; 56: 3-11.
42. Foster RG, Provencio I, Hudson D, Fiske S, DeGrip W, Menaker M. Circadian photoreception in the retinally degenerate mouse (rd/rd). J Comp Physiol 1991; 169:39-50.
43. Garcia-Fernandez JM, Jimenez AJ, Foster RG. The persistence of cone photoreceptors within the dorsal retina of aged retinally degenerate mice (rd/rd): implications for circadian organization. Neurosci Lett 1995; 187:33-36.
44. Moore RY. Entrainment pathways and the functional organization of the circadian system. Prog Brain Res 1996; 111:103-19.
45. Amir S, Robinson B. Ultraviolet light entrains rodent suprachiasmatic nucleus pacemaker. Neurosci 1995; 69:1005-11.
46. van den Pol, AN. Glutamate and aspartate immunoreactivity in hypothalamic presynaptic axons. J Neurosci 1991; 11:2087-2101.
47. Castel M, Belenky M, Cohen S, Ottersen, OP, Storm-Mathisen J. Glutamate-like immunoreactivity in retinal terminals of the mouse suprachiasmatic nucleus. Eur J Neurosci 1993; 5:368-81.
48. de Vries MJ, Cardozo BN, van der Want J, de Wolf A, Meijer JH. Glutamate immunoreactivity in terminals of the retinohypothalamic tract of the brown Norwegian rat. Brain Res 1993; 612:231-37.
49. Chen B, Pourcho RG. Morphological diversity and glutamate immunoreactivity of retinal terminals in the suprachiasmatic nucleus of the cat. J Comp Neuro 1995; 361:108-18.
50. Shibata S, Liou SY, Ueki S. Influence of excitatory amino acid receptor antagonists and of baclofen on synaptic transmission in the optic nerve to the suprachiasmatic nucleus in slices of rat hypothalamus. Neuropharmacology 1986; 25:403-9.
51. Cahill GM, Menaker M. Kynurenic acid blocks suprachiasmatic nucleus responses to optic nerve stimulation. Brain Res 1987; 410:125-29.
52. Cahill GM, Menaker M. Effects of excitatory amino acid receptor antagonists and agonists on suprachiasmatic nucleus responses to retinohypothalamic tract volleys. Brain Res 1989; 479:76-82.
53. Kim, YI, Dudek, FE. Intracellular electrophysiological study of suprachiasmatic nucleus in rodents: excitatory synaptic mechanisms. J Physiol 1991; 444:269-87.
54. Dudek FE, Kim YI, Bouskila Y. Electrophysiology of the suprachiasmatic nucleus: synaptic transmission, membrane properties, and neuronal synchronization. J Biol Rhythms 1993; 8:S33-S37.
55. Shirakawa T, Moore RY. Glutamate shifts the phase of the circadian neuronal firing rhythm in the rat suprachiasmatic nucleus in vitro. Neurosci Lett 1994; 178: 47-50.
56. Gannon RL, Rea MA. Glutamate receptor immunoreactivity in the rat suprachiasmatic nucleus. Brain Res 1993; 622:337-42.
57. Gannon RL, Rea MA. In situ hybridization of antisense mRNA oligonucleotides for AMPA, NMDA and metabotropic glutamate receptor subtypes in the rat suprachiasmatic nucleus at different phases of the circadian cycle. Mol Brain Res 1994; 23:338-44.
58. Mikkelsen JD, Larsen PJ, Ebling FJP. Distribution of N-methyl-D-aspartate (NMDA) receptor mRNAs in the rat suprachiasmatic nucleus. Brain Res 1993; 632:329-33.
59. O'hara BF, Andretic R, Heller HC, Carter DB, Kilduff TS. GABAA, GABAC, and NMDA receptor subunit expression in the suprachiasmatic nucleus and other brain regions. Mol Brain Res 1995; 28:239-50.
60. van den Pol, AN. Metabotropic glutamate receptor mGluR1 distribution and ultrastructural localization in hypothalamus. J Comp Neurol 1994; 349:615-32.
61. Romano C, Sesma MA, MacDonald C, O'Malley K, van den Pol AN, Olney JW. Immunocytochemical studies of the distribution of the metabotropic glutamate receptor mGluR5 in rat brain. J Comp Neurol 1995; 355:455-69.
62. Colwell, CS, Ralph, MR, Menaker, M. Do NMDA receptors mediate the effects of light on circadian behavior? Brain Res 1990; 523:117-120.
63. Colwell CS, Menaker M. NMDA as well as non-NMDA receptor antagonists can prevent the phase-shifting effects of light on the circadian system of the golden hamster. J Biol Rhythms 1992; 7:25-136.
64. Vindlacheruvu RR, Ebling FJP, Maywood ES, Hastings MH. Blockade of glutamatergic neurotransmission in the suprachiasmatic nucleus prevents cellular and behavioural responses of the circadian system to light. Eur J Neurosci 1992; 4: 673-79.
65. Rea MA, Buckley B, Lutton LM. Local administration of EAA antagonists blocks light-induced phase shifts and c-fos expression in the hamster SCN. Am J Physiol 1993; 265:R1191-R1198.
66. Ding JM, Chen D, Weber ET, et al. Resetting the biological clock: Mediation of nocturnal circadian shifts by glutamate and nitric oxide. Science 1994; 266: 1713-17.
67. Shibata S, Watanabe A, Hamada T, et al. Protein synthesis inhibitor blocks (R,S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) or substance P-induced phase shift of the circadian rhythm of neuronal activity in the rat suprachiasmatic nucleus in vitro. Neurosci Lett 1994; 168:159-62.
68. Meijer JH, van der Zee EA, Dietz M. Glutamate phase shifts circadian activity rhythms in hamsters. Neurosci Lett 1988; 86:177-83.
69. de Vries MJ, Meijer JH. Aspartate injections into the suprachiasmatic region of the Syrian hamster do not mimic the effects of light on the circadian activity rhythm. Neurosci Lett 1991; 127:215-18.
70. Rea, MA, Michel AM, Lutton LM. Is Fos necessary and sufficient to mediate light-induced phase advances? J Biol Rhythms 1993; 8(Suppl):S59-S64.
71. Moffett JR, Williamson L, Palkovits M, Namboodiri MAA. N-Acetylaspartylglutamate: a transmitter candidate for the retinohypothalamic tract. Proc Nat Acad Sci USA 1990; 87:8065-69.
72. Bos NP, Mirmiran M. Effects of excitatory and inhibitory amino acids on neuronal discharges in the cultured suprachiasmatic nucleus. Brain Res Bull 1993; 31: 67-72.
73. Takatsuji K, Miguel-Hidalgo JJ, Tohyama M. Substance P-immunoreactive innervation from the retina to the suprachiasmatic nucleus in the rat. Brain Res 1991; 568:223-29.
74. Mikkelsen JD, Larsen PJ. Substance P in the suprachiasmatic nucleus of the rat: an immunohistochemical and in situ hybridization study. Histochemistry 1993; 100:3-16.
75. Moore RY, Speh JC. A putative retinohypothalamic projection containing substance P in the human. Brain Res 1994; 659:249-53.
76. Larsen PJ. Distribution of substance P-immunoreactive elements in the preoptic area and the hypothalamus of the rat. J Comp Neurol 1992; 316:287-313.
77. Otori Y, Tominaga K, Fukuhara C, Yang J, Yamazaki S, Cagampang FR. Substance P-like immunoreactivity in the suprachiasmatic nucleus of the rat. Brain Res 1993; 619:271-77.
78. Hartwich M, Kalsbeek A, Pevet P, Nurnberger F. Effects of illumination and enucleation on substance-P-immunoreactive structures in subcortical visual centers of golden hamster and Wistar rat. Cell Tiss Res 1994; 277:351-61.
79. Takatsuji K, Tohyama M. Differential effects on substance P immunoreactivity in rat suprachiasmatic and olivary pretectal nuclei. Neuroreport 1993; 4:647-50.
80. Brecha NC, Sternini C, Anderson K, Krause JE. Expression and cellular localization of substance P/neurokinin A and neurokinin B mRNAs in the rat retina. Vis Neurosci 1989; 3:527-35.
81. Caruso DM, Owczarzak MT, Pourcho RG. Colocalization of substance P and GABA in retinal ganglion cells: a computer-assisted visualization. Vis Neurosci 1990; 5:389-94.
82. Mick G, Najimi M, Girard M, Chayvialle JA. Evidence for a substance P containing subpopulation in the primate suprachiasmatic nucleus. Brain Res 1992; 573: 311-17.
83. Swann JM, Macchione N. Photoperiodic regulation of substance P immunoreactivity in the mating behavior pathway of the male golden hamster. Brain Res 1992; 590:29-38.
84. Reuss S, Decker K, Hodl P, Sraka S. Anterograde neuronal tracing of retinohypothalamic projections in the hamster possible innervation of substance P-containing neurons in the suprachiasmatic nucleus. Neurosci Lett 1994; 174:51-54.
85. Reuss S, Burger K. Substance P-like immunoreactivity in the hypothalamic suprachiasmatic nucleus of Phodopus sungorus relation to daytime, photoperiod, sex and age. Brain Res 1994; 638:189-95.
86. Morin LP, Blanchard J, Moore RY. Intergeniculate leaflet and suprachiasmatic nucleus organization and connections in the golden hamsters. Vis Neurosci 1992; 8:219-30.
87. Shirakawa T, Moore RY. Responses of rat suprachiasmatic nucleus neurons to substance P and, glutamate in vitro. Brain Res 1994; 642:213-20.
88. Piggins HD, Cutler DJ, Rusak B. Ionophoretically applied substance P activates hamster suprachiasmatic nucleus neurons. Brain Res Bull 1995; 37:475-79.
89. Shibata S, Tsuneyoshi A, Hamada T, Tominaga K, Watababe S. Effect of substance P on circadian rhythms of firing activity and the 2-deoxyglucose uptake in the rat suprachiasmatic nucleus in vitro. Brain Res 1992; 597:257-63.
90. Abe H, Honma S, Shinohara K, Honma KI. Substance P receptor regulates the photic induction of Fos-like protein in the suprachiasmatic nucleus of Syrian hamsters. Brain Res 1996; 708:135-42.
91. Piggins HD, Rusak B. Effects of microinjections of substance P into the suprachiasmatic nucleus region on hamster wheel-running rhythms. Brain Res Bull 1997; 42:451-55.
92. Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 1991; 14:421-51.
93. Sheng M, Greenberg ME. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 1990; 4:477-85.
94. Sheng M, McFadden G, Greenberg ME. Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron 1990; 4:571-82.
95. Sagar SM, Sharp FR, Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 1988; 240:1328-31.
96. Curran T, Franza BR Jr. Fos and Jun: the AP-1 connection. Cell 1988; 55:395-97.
97. Curran T, Rauscher FJ, Cohen DR, Franza BR. Beyond the second messenger: oncogenes and transcription factors. Cold Spring Harbor Symp Quant Biol 1988; 53:769-77.
98. Rea, MA. Light increases Fos-related immunoreactivity in the rat suprachiasmatic nuclei. Brain Res Bull 1989; 23:577-81.
99. Rea, MA. Different populations of cells in the suprachiasmatic nuclei express c-fos in association with light-induced phase delays and advances of the free-running activity rhythm in hamsters. Brain Res 1992; 579:107-12.
100. Aronin N, Sagar SM, Sharp FR, Schwartz WJ. Light regulates expression of a Fos-related protein in rat suprachiasmatic nuclei. Proc Nat Acad Sci USA 1990; 87:5959-62.
101. Rusak B, Robertson HA, Wisden W, Hunt SP. Light pulses that shift rhythms induced gene expression in the suprachiasmatic nucleus. Science 1990; 248:1237-40.
102. Kornhauser JM, Nelson DE, Mayo KE, Takahashi JS. Photic and circadian regulation of c-fos gene expression in the hamster suprachiasmatic nucleus. Neuron 1990; 5:127-34.
103. Earnest DJ, Iadarola M, Yeh HH, Olschowka JA. Photic regulation of c-fos expression in neural components governing the entrainment of circadian rhythms. Exp Neurol 1990; 109:353-61.
104. Colwell CS, Foster RG. Photic regulation of Fos-like immunoreactivity in the suprachiasmatic nucleus of the mouse. J Comp Neurol 1992; 324:135-42.
105. Schwartz WJ, Takeuchi J, Shannon W, Davis EM, Aronin N. Temporal regulation of light-induced Fos and Fos-like protein expression in the ventrolateral subdivision of the rat suprachiasmatic nucleus. Neuroscience 1994; 58:573-83.
106. Sutin EL, Kilduff TS. Circadian and light-induced expression of immediate early gene mRNAs in the rat suprachiasmatic nucleus. Mol Brain Res 1992; 15:281-90.
107. Wollnik F, Brysch W, Uhlmann E, Gillardon F, Bravo R, Zimmerman M, Schlingensiepen KH, Herdegen T. Block of c-Fos and JunB expression by antisense oligonucleotides inhibits light-induced phase shifts of the mammalian circadian clock. Eur J Neurosci 1995; 7:388-93.
108. Rea MA, Michel AM, Lutton LM. Is Fos necessary and sufficient to mediate light-induced phase advances? J Biol Rhythms 1993; 8(Suppl):S59-S64.
109. Schwartz WJ, Peters RV, Aronin N, Bennett MR. Unexpected c-fos gene expression in the suprachiasmatic nucleus of mice entrained to a skeleton photoperiod. J Biol Rhythms 1996; 11:35-44.
110. Honrado GI, Johnson RS, Golombek DA, Spiegelman BM, Papaioannou VE, Ralph MR. The circadian system of c-fos deficient mice. J Comp Physiol A 1996; 178:563-70.
111. Mead SM, Ebling FJP, Maywood ES, Humby T, Herbert J, Hastings MH. A non-photic stimulus causes instantaneous phase advances of the light-entrainable circadian oscillator of the Syrian hamster, but does not induce the expression of c-fos in the suprachiasmatic nuclei. J Neurosci 1992; 12:2516-22.
112. Guido ME, Rusak B, Robertson HA. Expression of fos B mRNA in the hamster suprachiasmatic nucleus is induced at only selected circadian phases. Brain Res 1996; 739:132-38.
113. Peters RV, Aronin N, Schwartz WJ. Circadian regulation of Fos B is different from c-Fos in rat suprachiasmatic nucleus. Brain Res Mol Brain Res 1994; 27: 243-48.
114. Peters RV, Aronin N, Schwartz WJ. c-Fos expression in the rat intergeniculate leaflet: photic regulation, co-localization with Fos-B and cellular identification. Brain Res 1996; 728:231-41.
115. Ebling FJ, Maywood ES, Mehta M, Hancock DC, McNulty S, De Bono J, Bray SJ, Hastings MH. FosB in the suprachiasmatic nucleus of the Syrian and Siberian hamster. Brain Res Bull 1996; 41(5):257-68.
116. Kornhauser JM, Nelson DE, Mayo KE, Takahashi JS. Regulation of jun-B messenger RNA and AP-1 activity by light and a circadian clock. Science 1992; 255: 1581-84.
117. Rusak B, McNaughton L, Robertson HA, Hunt SP. Circadian variation in photic regulation of immediate-early gene mRNAs in rat suprachiasmatic nucleus cells. Mol Brain Res 1992; 14:124-30.
118. Takeuchi J, Shannon W, Aronin N, Schwartz WJ. Compositional changes of AP-1 DNA-binding proteins are regulated by light in a mammalian circadian clock. Neuron 1993; 11:825-36.
119. Kornhauser JM, Ginty DD, Greenberg ME, Mayo KE, Takahashi JS. Light entrainment and activation of signal transduction pathways in the SCN. Prog Brain Res 1996; 111:134-46.
120. Abe H, Rusak B, Robertson HA. NMDA and non-NMDA receptor antagonists inhibit photic induction of Fos protein in the hamster suprachiasmatic nucleus. Brain Res Bull 1992; 28:831-35.
121. Abe H, Rusak B, Robertson HA. Photic induction of c-Fos protein in the suprachiasmatic nucleus is inhibited by the NMDA-receptor antagonist MK-801. Neurosci Lett 1991; 127:9-12.
122. Ebling FJP, Maywood ES, Staley K, Humby T, Hancock DC, Waters CM, Evan GI, Hastings MH. The role of NMDA-type glutamatergic neurotransmission in the photic induction of immediate-early gene expression in the suprachiasmatic nuclei of the Syrian hamster. J Neuroendocrinol 1991; 3:641-52.
123. Rea MA, Buckley B, Lutton LM. Local administration of EAA antagonists blocks light-induced phase shifts and c-fos expression in the hamster SCN. Am J Physiol 1993; R1191-R1198.
124. Pickard GE, Weber ET, Scott PA, Riberdy A, Rea MA. 5HT1B receptor agonists inhibit light-induced phase shifts of behavioral circadian rhythms and expression of the immediate-early gene, c-fos, in the suprachiasmatic nucleus. J Neurosci 1996; 16:8208-20.
125. Rea MA. Different populations of cells in the suprachiasmatic nucleus express c-fos in association with light-induced phase delays and advances of the free-running activity rhythm in hamsters. Brain Res 1992; 579:107-12.
126. Chambille I, Doyle S, Serviere J. Photic induction and circadian expression of Fos-like protein. Immunohistochemical study in the retina and suprachiasmatic nuclei of hamster. Brain Res 1993; 612:138-50.
127. Klein DC, Moore RY. Pineal N-acetyltransferase and hydroxindole-o-methyltranferase: Control by the retinohypothalamic tract and the suprachiasmatic nucleus. Brain Res 1979; 174:245-62.
128. Earnest DJ, DiGiorgio SM, Olschowska JA. Light induces expression of fos-related proteins within gastrin releasing peptide neurons in the rat suprachiasmatic nucleus. Brain Res 1993; 627:205-9.
129. Mikkelsen JD, Larsen PJ, Sorensen GG, Woldbye D, Bolwig TG, Hastings MH, Ebling FJ. A dual-immunocytochemical method to localise c-fos protein in specific neurons based on their content of neuropeptides and connectivity. Histochemistry 1994; 101:245-51.
130. Silver R, Romero MT, Besmer HR, Leak R, Nunez JM, LeSauter J. Calbindin-D28K cells in the hamster SCN express light-induced Fos. Neuroreport 1996; 7: 1224-28.
131. Hastings MH, Best JD, Ebling FJP, Maywood ES, McNulty S, Schurov I, Selvage D, Sloper P, Smith KL. Entrainment of the circadian clock. Prog Brain Res 1996; 111:147-74.
132. Bennett MR, Schwartz WJ. Are glia among the cells that express immunoreactive c-Fos in the suprachiasmatic nucleus? Neuroreport 1994; 5:1737-40.
133. van den Pol AN, Tsujimoto KL. Neurotransmitters of the hypothalamic suprachiasmatic nucleus: immunocytochemical analysis of 25 neuronal antigens. Neuroscience 1985; 15:1049-86.
134. Ibata Y, Takahashi Y, Okamura H, Kawakami F, Terubayashi H, Kubo T, Yanaihara N. Vasoactive intestinal peptide (VIP)-like immunoreactive neurons located in the rat suprachiasmatic nucleus receive a direct retinal projection. Neurosci Lett 1989; 97:1-5.
135. Reuss S, Decker K. Anterograde tracing of retinohypothalamic afferents with Fluoro-Gold. Brain Res 1997; 745:197-204.
136. Romijn HJ, Sluiter AA, Pool CW, Wortel J, Buijs RM. Differences in colocalization between fos and PHI, GRP, VIP and VP in neurons of the rat suprachiasmatic nucleus after a light stimulus during the phase delay versus the phase advance period of the night. J Comp Neurol 1996; 372:1-8.
137. Ignarro, LJ. Nitric oxide: a novel signal transduction mechanism for transcellular communication. Hypertension 1990; 16:477-83.
138. Marietta MA, Tayeh MA, Hevel JM. Unraveling the biological significance of nitric oxide. Biofactors 1990; 2:219-25.
139. Brenman JE, Bredt DS. Nitric oxide signaling in the nervous system. Methods in Enzymol 1996; 269:119-29.
140. Feng Q, Hedner T. Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). I. Physiology, pharmacology and pathophysiological implications. Clin Physiol 1990; 10:407-26.
141. Lowenstein CJ, Snyder SH. Nitric oxide, a novel biologic messenger. Cell 1990; 70:705-7.
142. Snyder SH. Nitric oxide and neurons. Curr Opin Neurobiol 1990; 2:323-27.
143. Dawson VL, Dawson TM. Nitric oxide actions in neurochemistry. Neurochem Int 1996; 29:97-110.
144. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347:768-70.
145. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351:714-18.
146. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Nat Acad Sci USA 1990; 87:682-85.
147. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Nat Acad Sci USA 1989; 86:9030-33.
148. Southam E, East SJ, Garthwaite J. Excitatory amino acid receptors coupled to nitric oxide/cyclic GMP pathway in rat cerebellum during development. J Neurochem 1991; 56:2072-81.
149. Gaily JA, Montague PR, Reeke GN, Edelman GM. The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc Nat Acad Sci USA 1990; 87:3547-51.
150. Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 1992; 32:297-311.
151. Southam E, Garthwaite J. Nitric oxide-cyclic GMP pathway in brain slices. Methods in Enzymol 1996; 269:129-33.
152. Amir S. Blocking NMDA receptors or nitric oxide production disrupts light transmission to the suprachiasmatic nucleus. Brain Res 1992; 586:336-39.
153. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101:746-52.
154. Watanabe A, Hamada T, Shibata S, Watanabe S. Effects of nitric oxide synthase inhibitors on N-methyl-D-aspartate-induced phase delay of circadian rhythm of neuronal activity in the rat suprachiasmatic nucleus in vitro. Brain Res 1994; 646: 161-64.
155. Watanabe A, Ono M, Shibata S, Watanabe S. Effect of a nitric oxide synthase inhibitor, N-nitro-L-arginine methylester, on light-induced phase delay of circadian rhythm of wheel-running activity in golden hamsters. Neurosci Lett 1995; 192: 25-28.
156. Weber ET, Gannon RL, Gillette MU, Rea MA. Nitric oxide synthesis inhibitor blocks light-induced phase shifts of the circadian activity rhythm, but not Fos expression in the suprachiasmatic nucleus of the hamster. Brain Res 1995; 137-42.
157. Amir S, Edelstein K. A blocker of nitric oxide synthase, NG-nitro-L-arginine methyl ester, attenuates light-induced Fos protein expression in rat suprachiasmatic nucleus. Neurosci Lett 1997; 224:29-32.
158. Weber ET, Gannon RL, Rea MA. Cyclic GMP-dependent protein kinase inhibitor blocks light-induced phase advances of the circadian activity rhythms. Neurosci Lett 1995; 197:227-30.
159. Mathur A, Golombek DA, Ralph MR. cGMP-dependent protein kinase inhibitors block light-induced phase advances of circadian rhythms in vivo. Am J Physiol 1996; 270:R1031-R1036.
160. Decker K, Reuss S. Nitric oxide-synthesizing neurons in the hamster suprachiasmatic nucleus: a combined NOS and NADPH-staining and retinohypothalamic tract tracing study. Brain Res 1994; 666:284-88.
161. Reuss S, Decker K, Rosseler L, Layes E, Schollmayer A, Spessert R. Nitric oxide synthase in the hypothalamic suprachiasmatic nucleus of rat: evidence from histochemistry, immunohistochemistry and western blot; and colocalization with VIP. Brain Res 1995; 695:257-62.
162. Amir S, Robinson B, Edelstein K. Distribution of NADPH-diaphorase staining and light-induced Fos expression in the rat suprachiasmatic nucleus region supports a role for nitric oxide in the circadian system. Neuroscience 1995; 69: 545-55.
163. Lupi D, Debernardis D, Vallerga S, Morgan PJ, Djamgoz BA. NADPH diaphorase activity around the suprachiasmatic nucleus in rat brain. Cell Tiss Res 1996; 283: 335-38.
164. Vincent SR, Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 1992; 46:755-84.
165. Chen D, Hurst WJ, Ding JM, Faiman L, Mayer B, Gillette MU. Localization and characterization of nitric oxide synthase in the rat suprachiasmatic nucleus: evidence of a nitrergic plexus in the biological clock. J Neurochem 1997; 68:855-61.
166. Azmitia EC, Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal median raphe nuclei in the rat. J Comp Neurol 1978; 179:641-68.
167. Moore RY, Halaris AE, Jones BE. Serotonin neurons of the midbrain raphe: ascending projections. J Comp Neurol 1978; 180:417-38.
168. van de Kar LD, Lorens SA. Differential serotonergic innervation of hypothalamic nuclei and other forebrain regions by dorsal and median midbrain raphe nuclei. Brain Res 1979; 162:45-54.
169. Bosler O, Beaudet A. VIP neurons as prime synaptic targets for serotonin afferents in rat suprachiasmatic nucleus: a combined radioautographic and immunocytochemical study. J Neurocytol 1985; 14:749-63.
170. Francois-Bellan AM, Bosler O. Convergent serotonin and GABA innervation of VIP neurons in the suprachiasmatic nucleus demonstrated by triple labeling in the rat. Brain Res 1992; 595:149-53.
171. Meyer-Bernstein EL, Morin LP. Differential serotonergic innervation of the suprachiasmatic nucleus and the intergeniculate leaflet and its role in circadian rhythm modulation. J Neurosci 1996; 16:2097-2111.
172. Meyer-Bernstein EL, Blanchard JH, Morin LP. The serotonergic projection from the median raphe nucleus to the suprachiasmatic nucleus modulates activity phase onset, but not other circadian rhythm parameters. Brain Res 1997; 755:112-20.
173. Ueda S, Kawata M, Sano Y. Identification of serotonin- and vasopressin immunoreactivities in the suprachiasmatic nucleus of four mammalian species. Cell Tisssue Res 1983; 234:237-48.
174. Nishino H, Koizumi K. Responses of neurons in the suprachiasmatic nuclei of the hypothalamus to putative neurotransmitters. Brain Res 1977; 120:167-72.
175. Groos GA, Mason R, Meijer J. Electrical and pharmacological properties of the suprachiasmatic nuclei. Fed Proc 1983; 42:2790-94.
176. Mason R. Circadian variation in sensitivity of suprachiasmatic and lateral geniculate neurones to 5-hydroxytryptamine in the rat. J Physiol (Lond) 1986; 377:1-13.
177. Block M, Zucker I. Circadian rhythms of rat locomotor activity after lesions of the midbrain raphe nuclei. J Comp Physiol 1976; 109:235-47.
178. Szafarczyk A, Alonso G, Ixart G, Malaval F, Nouguier-Soule J, Assenmacher I. Serotonergic system and circadian rhythms of ACTH and corticosterone in rats. Am J Physiol 1980; 239:E482-E489.
179. Szafarczyk A, Ixart G, Alonso G, Malavel F, Nouguier-Soule J, Assenmacher I. Effects of raphe lesions on circadian ACTH, corticosterone and motor activity rhythms in free-running blinded rats. Neurosci Lett 1981; 23:92-97.
180. Levine JD, Rosenwasser AM, Yanovski JA, Adler NT. Circadian activity rhythms in rats with midbrain lesions. Brain Res 1986; 445:222-27.
181. Smale L, Michels KM, Moore, RY, Morin LP. Destruction of the hamster serotonergic system by 5,7-DHT: effects on circadian rhythm phase, entrainment, and response to triazolam. Brain Res 1990; 515:9-19.
182. Morin LP, Blanchard J. Depletion of brain serotonin by 5-7-DHT modifies hamster circadian rhythm response to light. Brain Res 1991; 566:173-85.
183. Morin LP, Blanchard J. Serotonergic modulation of the hamster wheelrunning rhythm in response to lighting conditions and food deprivation. Brain Res 1991; 566:186-92.
184. Szafarczyk A, Ixart G, Malaval F, Nouguier-Soule J, Assenmacher I. Effect of lesions of the suprachiasmatic nuclei and of p-chlorophenyl-alanine on the circadian rhythms of adreno-corticotrophic hormone and corticosterone in the plasma, and locomotor activity in rats. J Endocrinol 1979; 83:1-16.
185. Honma KI, Watanabe K, Hiroshige T. Effects of parachlorophenylalanine and 5,6-dihydroxytryptamine on the free-running rhythms of locomotor activity and plasma corticosterone in the rat exposed to continuous light. Brain Res 1979; 169: 531-44.
186. Duncan WC, Tamarkin L, Sokolove PG, Wehr TA. Chronic chlorgyline treatment of Syrian hamsters: an analysis of effects on the circadian pacemaker. J Biol Rhythms 1988; 3:305-22.
187. Prosser RA, Miller JD, Heller HC. A serotonin agonist phase-shifts the circadian clock in the suprachiasmatic nuclei in vitro. Brain Res 1990; 534:336-39.
188. Prosser RA, Heller HC, Miller JD. Serotonergic phase shifts of the mammalian circadian clock: effects of tetrodotoxin and high Mg2+. Brain Res 1992; 573: 336-40.
189. Prosser PA, Dean RR, Edgar DM, Heller HC, Miller JS. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists. J Biol Rhythms 1993; 8:1-16.
190. Medanic M, Gillette MU. Serotonin regulates the phase of the rat suprachiasmatic circadian pacemaker in vitro during the subjective day. J Physiol (Lond) 1992; 450:629-42.
191. Shibata S, Tsuneyoshi A, Hamada T, Tominaga K, Watanabe S. Phase resetting effect of 8-OH-DPAT, a serotonin1A receptor agonist, on the circadian rhythm of firing rate in the rat supra-chiasmatic nuclei in vitro. Brain Res 1992; 582:353-56.
192. Green DJ, Gillette R. Circadian rhythm of firing rat recorded from single cells in the rat suprachiasmatic brain slice. Brain Res 1982; 245:198-200.
193. Gillette MU, Reppert SM. The hypothalamic suprachiasmatic nuclei: Circadian patterns of vasopressin secretion and neuronal activity in vitro. Brain Res Bull 1987; 19:135-39.
194. Shibata S, Tsuneyoshi A, Hamada T, Tominaga K, Watanabe S. Phase resetting effect of 8-OH-DPAT, a serotonin1A receptor agonist, on the circadian rhythm of firing rate in the rat supra-chiasmatic nuclei in vitro. Brain Res 1992; 582:353-56.
195. Lovenberg TW, Baron BM, de Lecea L, Miller JS, Prosser RA, Rea MA, Foye PE, Racke M, Slone AL, Siegel BW, Danielson PE, Sutcliffe JG, Erlander MG. A novel adenylate cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 1993; 11:449-58.
196. Tominaga K, Shibata S, Ueki, S, Watanabe S. Effects of 5-HT1A agonists on the circadian rhythm in wheel running activity in hamsters. Eur J Pharmacol 1992; 214:79-84.
197. Edgar DM, Miller JD, Prosser RA, Dean RR, Dement WC. Serotonin and the mammalian circadian system: II. Phase-shifting rat behavioral rhythms with serotonergic agonists. J Biol Rhythms 1993; 8:17-13.
198. Cutrera RA, Ouarour A, Pevet P. Effects of the 5HT1A receptor agonist, 8-OH-DPAT and other non-photic stimuli on the circadian rhythm of wheel-running activity in hamsters under different constant conditions. Neurosci Lett 1994; 172: 27-30.
199. Cutrera RA, Saboureau, Pevet P. Phase-shifting effect of 8-OH-DPAT, a 5HT 1A/5HT7 receptor agonist, on locomotor activity in golden hamster in constant darkness. Neurosci Lett 1996; 210:1-4.
200. Mintz EM, Gillespie CF, Marvel CL, Huhman KL, Albers HE. Serotonergic regulation of circadian rhythms in Syrian hamsters. Neuroscience 1997; 79:563-69.
201. Penev PD, Turek FW, Zee PC. Monoamine depletion alters the entrainment and the response of the circadian activity rhythm in hamsters. Brain Res 1993; 612: 156-64.
202. Miller JD, Fuller CA. The response of suprachiasmatic neurons of the rat hypothalamus to photic and serotonergic stimulation. Brain Res 1990; 515:155-62.
203. Ying S-W, Rusak B. Effects of serotonergic agonists on firing rates of photically responsive cells in the hamster suprachiasmatic nucleus. Brain Res 1994; 651: 37-46.
204. Ying S-W, Rusak B. 5HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons. Brain Res 1997; 755:246-54.
205. Liou SY, Shibata S, Ueki S. Effect of monoamines on field potentials in the suprachiasmatic nucleus of slices of hypothalamus of the rat evoked by stimulation of the optic nerve. Neuropharmacology 1986; 25:1009-14.
206. Rea MA, Glass JD, Colwell CS. Serotonin modulates the photic response of the SCN circadian oscillator. J Neurosci 1994; 14:3635-42.
207. Selim M, Glass JD, Hauser UE, Rea MA. Serotonergic inhibition of light-induced Fos protein expression and extracellular glutamate in the suprachiasmatic nuclei. Brain Res 1993; 621:181-88.
208. Glass JD, Selim M, Rea MA. Modulation of light-induced c-fos expression in the suprachiasmatic nuclei by 5-HT1A receptor agonists. Brain Res 1994; 638: 235-42.
209. Weber ET, Gannon RL, Rea MA. Local administration of serotonin agonists blocks light-induced phase advances of the circadian activity rhythm in the hamster. J Biol Rhythms 1998; 13:209-18.
210. Rea MA, Barrera J, Glass JD, Gannon RL. Serotonergic potentiation of photic phase shifts of the circadian activity rhythm. NeuroReport 1995; 6:1417-20.
211. Glass JD, Selim M, Hauser UE, Srkalovic G, Rea MA. Tryptophan loading modulates light-induced responses of the mammalian circadian pacemaker. J Biol Rhythms 1995; 10:80-90.
212. Rea MA, Cato MJ, Weber ET. Electrical stimulation of the dorsal raphe nucleus modulates circadian phase in hamsters. Soc Neurosci Abst 1997; 23:790.
213. Meyer-Bernstein EL, Morin LP. Electrical stimulation of either the median or dorsal raphe nucleus blocks light-induce fos expression in the suprachiasmatic nucleus. Soc Neurosci Abst 1997; 23:21.
214. Sumner BEH, Rosie R, Fink G. Relative density of 5-hydroxytryptamine receptor subtype mRNAs in female rat neuroendocrine brain determined by in situ hybridization histochemistry. Mol Cell Neurosci 1992; 3:215-23.
215. Roca AL, Weaver DR, Reppert SM. Serotonin receptor gene expression in the rat suprachiasmatic nucleus. Brain Res 1993; 608:159-65.
216. Kia HK, Miquel MC, Brisorgueil MJ, Daval G, Riad M, Mestikawy S, Hamon M, Verge D. Immunocytochemical localization of serotonin 1A receptors in the rat central nervous system. J Comp Neurol 1996; 365:289-305.
217. Ruat M, Traiffort E, Leurs R, Tradivel-Lacombe J, Diaz J, Arrang J, Schwarz J. Molecular cloning, characterization, and localization of a high affinity serotonin receptor (5HT7) activating cAMP formation. Proc Nat Acad Sci USA 1993; 90: 8547-51.
218. Shen Y, Monsma FJ, Metcalf MA, Jose PA, Hamblin MW, Sibley DR. Molecular cloning and expression of a 5-hydroxytryptamine serotonin receptor subtype. J Biol Chem 1993; 268:18200-4.
219. Scott PA, Cagle M, Rea MA. Serotonin receptor binding and mRNA expression in the rat suprachiasmatic nucleus. Soc Neurosci Abst 1996; 22:1141.
220. Kawahara F, Saito H, Katsuki H. Inhibition by 5HT7 receptor stimulation of GABA a receptor-activated current in cultured rat suprachiasmatic neurones. J Neurophysiol 1994; 478:67-73.
221. Guy J, Bosler O, Dusticier G, Pelletier G, Calas A. Morphological correlates of serotonin-neuropeptide Y interactions in the rat suprachiasmatic nucleus: combined radioautoradiographic and immunocytochemical data. Cell Tiss Res 1987; 250:657-62.
222. Bosler O. Ultrastructural relationships of serotonin and GABA terminals in the rat suprachiasmatic nucleus. Evidence for a close interconnection between two afferent systems. J Neurocytol 1989; 18:105-13.
223. Pickard GE, Rea MA. 5HT1B receptor agonists block light-induced phase shifts and fos expression in the mouse SCN. Neurosci Lett 1997; 231:95-98.
224. Boschert U, Amara DA, Segu L, Hen R. The mouse 5-hydroxtryptamine1B receptor is localized predominately on axon terminals. Neuroscience 1994; 58:167-82.
225. Manrique C, Segu L, Hery F, Faudon M, Francois-Bellan AM. Increase of central 5HT1B binding sites following 5,7-dihydroxytryptamine axotomy in the adult rat. Brain Res 1993; 623:345-48.
226. Mooney RD, Shi MY, Rhoades RW. Modulation of retinotectal transmission by presynaptic 5-HT1B receptors in the superior colliculus of the adult hamster. J Neurophysiol 1994; 72:3-13.
227. Srkalovic G, Selim M, Rea MA, Glass JD. Serotonergic inhibition of extracellular glutamate in the suprachiasmatic nuclear region assessed using in vivo brain microdialysis. Brain Res 1994; 656:302-8.